UiPath Inc (PATH) Stock Price Today
Aura AI Summary
Key Stats
- $6.05BMarket Cap
- -Volume
- TechnologySector
- $19.2952W High
- $9.3852W Low
- -Typical Hold Time
- $4.83BEnterprise Value
- -Div Yield
- -Trading Activity
Track UiPath Inc (PATH) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, UiPath Inc has traded between a low of $9.38 and a high of $19.29, highlighting its annual price range. Buy and sell UiPath Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About UiPath Inc
UiPath Inc creates an end-to-end platform that provides automation with user emulation at its core. Its platform is built to be used by employees throughout a company and to address a wide variety of use cases, from simple tasks to long-running, complex business processes. It generates revenue from the sale of licenses for its proprietary software, maintenance and support, and professional services. It generates a majority of the revenues from the US, followed by Romania and the rest of the world.
Most Recent News
Quadient named Leader in 2026 SPARK Matrix for transforming customer communications with AI and flexibility
Quadient has been recognized as a Leader in the 2026 SPARK Matrix for Customer Communications Management by QKS Group for the sixth consecutive year. The report highlights Quadient's strength in evolving CCM from traditional document production to an...
Quadient named Leader in 2026 SPARK Matrix for customer communications management for 6th year
Quadient has been recognized as a Leader in the 2026 SPARK Matrix for Customer Communications Management (CCM) by QKS Group for the sixth consecutive year. This highlights Quadient's strength in transforming traditional document production into an AI...
Disposable endoscopes market to reach $10.47B by 2035, driven by infection control and minimally invasive procedures.
The global disposable endoscopes market, valued at $2.58 billion in 2025, is projected to grow to $10.47 billion by 2035 with a CAGR of 15.04%. Growth is fueled by rising demand for single-use endoscopes, infection prevention efforts, and increased u...
People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.